# Tvardi Therapeutics, Inc. (TVRD)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/TVRD/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -6.80M | $ -5.86M | $ 174.0K | $ 14.51M |
| 2025 | $ 2.63M | $ -13.86M | $ -27.13M | $ 201.0K | $ 20.95M |
| 2024 | $ 2.24M | $ -58.75M | $ -65.13M | $ 44.45M | $ -4.59M |
| 2023 | $ 8.51M | $ -65.27M | $ -27.81M | $ 368.0K | $ -62.06M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.01 |
| Liabilities / Eq | 0.78 |
| Current Ratio | 2.25 |

## Other views

- [Metrics](https://sponda.capital/en/TVRD.md)
- [Charts](https://sponda.capital/en/TVRD/charts.md)
- [Compare](https://sponda.capital/en/TVRD/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-13.